Skip to Main content Skip to Navigation
Master Thesis

Effets du sacubitril/valsartan sur la néprilysine et le métabolisme des peptides natriurétiques dans l'insuffisance cardiaque chronique : étude clinique mécanistique

Abstract : Aim: this study aimed at evaluating the effects of sacubitril/valsartan on neprilysin (NEP), and the metabolism of natriuretic peptides in heart failure (HF) and providing additional mechanistic information on the mode of action of the drug. Methods and results: we enrolled 73 chronic HF patients who were switched from angiotensin-converting enzyme inhibitor or angiotensin receptor blocker to sacubitril/valsartan. In addition to clinical and echocardiographic assessment, plasma biomarkers were measured at baseline, day 30 and day 90 after initiation of treatment. Sacubitril/valsartan led to decrease in New York Heart Association class and improvement of echocardiographic parameters, as well as a dose-dependent decrease in soluble NEP (sNEP) activity, while sNEP concentration remained unchanged. Neprilysin inhibition translated into an increase in its substrates such as atrial natriuretic peptide (ANP), substance P, and glucagon-like peptide 1, the latter translating into a decrease in fructosamine. Cardiac troponin and soluble ST2 levels, biomarkers of HF severity unrelated to NEP metabolism also decreased. While there was a ~4-fold increase in ANP, we observed no change in plasma brain natriuretic peptide (BNP) and plasma BNP activity, and a mild decrease in N-terminal proBNP (NT-proBNP) concentrations. Finally, we found a progressive increase in the relationship between BNP and NT-proBNP, which strongly correlated with an increase in T71 proBNP glycosylation (R2 = 0.94). Conclusion: sacubitril/valsartan rapidly and strongly reduced sNEP activity, leading to an increase in levels of NEP substrates.These data suggest a pleiotropic favourable impact of sacubitril/valsartan on the metabolism of HF patients with ANP rather than BNP as major effectors amongst natriuretic peptides.
Document type :
Master Thesis
Complete list of metadata

https://dumas.ccsd.cnrs.fr/dumas-03197305
Contributor : Université Paris Descartes - Scd Connect in order to contact the contributor
Submitted on : Tuesday, April 13, 2021 - 4:38:49 PM
Last modification on : Friday, September 3, 2021 - 3:32:56 AM

File

ThExe_PEZEL_Theo_DUMAS.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

  • HAL Id : dumas-03197305, version 1

Citation

Théo Pezel. Effets du sacubitril/valsartan sur la néprilysine et le métabolisme des peptides natriurétiques dans l'insuffisance cardiaque chronique : étude clinique mécanistique. Médecine humaine et pathologie. 2019. ⟨dumas-03197305⟩

Share

Metrics

Record views

9

Files downloads

5